132 related articles for article (PubMed ID: 9223163)
1. Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon.
Roeffen W; Mulder B; Teelen K; Bolmer M; Eling W; Targett GA; Beckers PJ; Sauerwein R
Parasite Immunol; 1996 Feb; 18(2):103-9. PubMed ID: 9223163
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.
Roeffen W; Beckers PJ; Teelen K; Lensen T; Sauerwein RW; Meuwissen JH; Eling W
Exp Parasitol; 1995 Feb; 80(1):15-26. PubMed ID: 7529717
[TBL] [Abstract][Full Text] [Related]
3. A comparison of transmission-blocking activity with reactivity in a Plasmodium falciparum 48/45-kD molecule-specific competition enzyme-linked immunosorbent assay.
Roeffen W; Lensen T; Mulder B; Teelen K; Sauerwein R; Van Druten J; Eling W; Meuwissen JH; Beckers PJ
Am J Trop Med Hyg; 1995 Jan; 52(1):60-5. PubMed ID: 7856826
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum: membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon.
Mulder B; Lensen T; Tchuinkam T; Roeffen W; Verhave JP; Boudin C; Sauerwein R
Exp Parasitol; 1999 May; 92(1):81-6. PubMed ID: 10329369
[TBL] [Abstract][Full Text] [Related]
5. Transmission-blocking effects of sera from malaria-exposed individuals on Plasmodium falciparum isolates from gametocyte carriers.
Drakeley CJ; Mulder L; Tchuinkam T; Gupta S; Sauerwein R; Targett GA
Parasitology; 1998 May; 116 ( Pt 5)():417-23. PubMed ID: 9614324
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.
Paul NH; Vengesai A; Mduluza T; Chipeta J; Midzi N; Bansal GP; Kumar N
Acta Trop; 2016 Nov; 163():103-8. PubMed ID: 27491342
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serological tests and bio-assay for malaria transmission blocking capacity in field sera.
Roeffen W; Beckers PJ; Teelen K; Verhave JP; Eling W; Sauerwein R
Parassitologia; 1993 Jul; 35 Suppl():95-7. PubMed ID: 7694226
[TBL] [Abstract][Full Text] [Related]
8. Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.
Kundu P; Semesi A; Jore MM; Morin MJ; Price VL; Liang A; Li J; Miura K; Sauerwein RW; King CR; Julien JP
Nat Commun; 2018 Oct; 9(1):4458. PubMed ID: 30367064
[TBL] [Abstract][Full Text] [Related]
9. The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.
Bousema T; Roeffen W; Meijerink H; Mwerinde H; Mwakalinga S; van Gemert GJ; van de Vegte-Bolmer M; Mosha F; Targett G; Riley EM; Sauerwein R; Drakeley C
PLoS One; 2010 Nov; 5(11):e14114. PubMed ID: 21124765
[TBL] [Abstract][Full Text] [Related]
10. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
Healer J; McGuinness D; Carter R; Riley E
Parasitology; 1999 Nov; 119 ( Pt 5)():425-33. PubMed ID: 10599074
[TBL] [Abstract][Full Text] [Related]
11. Properties of epitopes of Pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum.
Carter R; Graves PM; Keister DB; Quakyi IA
Parasite Immunol; 1990 Nov; 12(6):587-603. PubMed ID: 1707506
[TBL] [Abstract][Full Text] [Related]
12. Conserved and variant epitopes of target antigens of transmission-blocking antibodies among isolates of Plasmodium falciparum from Malaysia.
Foo A; Carter R; Lambros C; Graves P; Quakyi I; Targett GA; Ponnudurai T; Lewis GE
Am J Trop Med Hyg; 1991 Jun; 44(6):623-31. PubMed ID: 1713424
[TBL] [Abstract][Full Text] [Related]
13. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.
Chowdhury DR; Angov E; Kariuki T; Kumar N
PLoS One; 2009 Jul; 4(7):e6352. PubMed ID: 19623257
[TBL] [Abstract][Full Text] [Related]
14. Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates.
Jones S; Grignard L; Nebie I; Chilongola J; Dodoo D; Sauerwein R; Theisen M; Roeffen W; Singh SK; Singh RK; Singh S; Kyei-Baafour E; Tetteh K; Drakeley C; Bousema T
J Infect; 2015 Jul; 71(1):117-27. PubMed ID: 25869538
[TBL] [Abstract][Full Text] [Related]
15. Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies.
Outchkourov N; Vermunt A; Jansen J; Kaan A; Roeffen W; Teelen K; Lasonder E; Braks A; van de Vegte-Bolmer M; Qiu LY; Sauerwein R; Stunnenberg HG
J Biol Chem; 2007 Jun; 282(23):17148-56. PubMed ID: 17426022
[TBL] [Abstract][Full Text] [Related]
16. Human antibody responses to epitopes on the Plasmodium falciparum gametocyte antigen PFS 48/45 and their relationship to infectivity of gametocyte carriers.
Graves PM; Doubrovsky A; Sattabongkot J; Battistutta D
Am J Trop Med Hyg; 1992 Jun; 46(6):711-9. PubMed ID: 1377881
[TBL] [Abstract][Full Text] [Related]
17. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing.
Read D; Lensen AH; Begarnie S; Haley S; Raza A; Carter R
Parasite Immunol; 1994 Oct; 16(10):511-9. PubMed ID: 7532850
[TBL] [Abstract][Full Text] [Related]
18. Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.
Wizel B; Kumar N
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9533-7. PubMed ID: 1719534
[TBL] [Abstract][Full Text] [Related]
19. Detection of anti-Plasmodium falciparum antibodies directed against a repetitive peptide of the gametocyte antigen Pfs2400 in malaria patients in Brazil.
Marrelli MT; Nussenzweig RS; Collins WE; Kloetzel JK
Ann Trop Med Parasitol; 1995 Dec; 89(6):593-99. PubMed ID: 8745934
[TBL] [Abstract][Full Text] [Related]
20. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
